Construction of an Integration Vector with a Chimeric Signal Peptide for the Expression of Monoclonal Antibodies in Mammalian Cells
2024

New Vector for Making Antibodies in Cells

Sample size: 68 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nesmeyanova Valentina S., Shanshin Daniil V., Murashkin Denis E., Shcherbakov Dmitriy N.

Primary Institution: State Scientific Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, Russia

Hypothesis

Can a new integrative vector improve the production of monoclonal antibodies in mammalian cells?

Conclusion

The new vector successfully produced a monoclonal antibody with high levels of expression and functional activity.

Supporting Evidence

  • Over 95% of clones secreted antibodies at levels significantly higher than the control.
  • The recombinant antibody yield was 15 mg/L without optimization.
  • The developed vector includes multiple regulatory elements to enhance expression.
  • The functional activity of the produced antibody was confirmed through immunochemical analysis.

Takeaway

Scientists created a new tool to help cells make antibodies better, and it worked really well in tests.

Methodology

The study involved designing a new vector, transfecting it into CHO-K1 cells, and analyzing the antibody production through ELISA.

Limitations

The study did not optimize the cultivation conditions for antibody production.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cimb46120868

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication